1 / 47

Enhancing Budget Monitoring and Expenditure Tracking for Health Issues and Marginalised Groups

Enhancing Budget Monitoring and Expenditure Tracking for Health Issues and Marginalised Groups. Bucharest Workshop ~ OSI Partners 17/18 th October 2008 Teresa Guthrie Centre for Economic Governance and AIDS in Africa. Centre for Economic Governance and AIDS in Africa.

willa
Télécharger la présentation

Enhancing Budget Monitoring and Expenditure Tracking for Health Issues and Marginalised Groups

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Enhancing Budget Monitoring and Expenditure Tracking for Health Issues and Marginalised Groups Bucharest Workshop ~ OSI Partners 17/18th October 2008 Teresa Guthrie Centre for Economic Governance and AIDS in Africa

  2. Centre for Economic Governance and AIDS in Africa CEGAA aims to contribute to improved economic governance, fiscal policy and financial management and accountability, with specific attention to improving the response to HIV and AIDS. • Through ~ economic and budget analysis research, training and capacity building, and advocacy activities • With ~ civil society orgs, independent research agencies, parliamentarians and Ministries of Health and National AIDS Commissions.

  3. Overview of this Presentation • Potential scope for budget monitoring and expenditure tracking • Different foci & methods in BMET • Costing • Budget monitoring • Expenditure tracking • Examples of evidence-based advocacy using BMET data • Key decisions in developing the Project TORs

  4. Transparency & Accountability ~ Govt Allocation & Expenditure Processes • Govt Budget is a powerful economic policy tool to balance the revenue & expenditure, maintain fiscal discipline, and translate policies into services. Undermined by IMF/ WB conditionalities. • Budget allocation is powerful indicator of the priorityaccorded to health (or other issue), more than policy or legislation, and are key to the sustainability of programmes. • Participatory, transparent, accountable budget & expenditure systems indicate degree democracy in the country. • Budget Allocations do not equate to actual Expenditure • Monitoring of allocations & expenditure depends upon strong financial information systems!

  5. BMET compliments policy & service analysis & strengthens advocacy Policy Policy Analysis BUDGET $$ Prog.Evaluation BMET Services

  6. Definitions • Costing – determining required resources, quantities, their costs and calculating total cost for an intervention • Budgeting – a plan to manage the available resources, within a specific timeframe (usually 1year) according to the project plan (intended allocations) • Expenditure – those resources spent on particular interventions • Adequacy – are the inputs sufficient to achieve intended goals – implies knowledge of how much is needed. • Efficacy / Effective – achieves its intended outputs or outcomes – implies programme plan.

  7. Definitions cont. • Efficient – achieves its outputs with the best use of inputs/ resources – most cost-efficient. • Allocative efficiency – best choice of type of intervention between different types of intervention (eg. Prevention activities vs treatment activities. • Technical efficiency – best choice of intervention from same type of interventions (eg. Within treatment options, best and cheapest ARVs). • Operational efficiency – intervention is run/ implemented as efficiently as possible. • Programme outputs – immediate tangible products • Programme outcomes – results of the outputs • Programme impact –longer-term effects (the overall purpose for the intervention)

  8. Fiscal Cycle ~ Different Phases & Methods Assessment of Resource Need – costing analysis Budget Monitoring Process Actual amounts Revenue & tax Sector analysis Budget Allocations – indication of intended PUBLIC expenditure Your use of the data will influence all these aspects Public Private Donor Outcome analysis – long-term indicators. Impact assessment Actual Expenditure – execution of budget. Can include all sources of funds and by all service providers National Provincial District Life years saved Quality of life Reduced prevalence rates Causal link Effectiveness (CEA/CBA/CUA) Expenditure Analysis Process/finance channels Actual amounts Output analysis – interim indicators comparing with objectives of expenditure Outputs Social Auditing Effectiveness Quality

  9. Linking Resource Need Estimates to Allocation Analysis to Expenditure Estimates Howmuchwasspent Howmuchwasallocated Howmuchisneeded • Throughgovernment • Public • Foreign • Private • Through private orgs/NGOs • In strategicprograms • Targeted IEC • Condoms • PMTCT • STI treatment • VTC • ARV treatment • IO treatment • Palliativeservices • Social ImpactMitigation • Staff training • Research • Beneficiaries? • Outputs • At global level • At nationallevel • MOH • Otherministries • NGO, CSO, CBO • At provincelevel • Tertiary, Secondary • Primarylevel • NGO, CSO, CBO • At local level • In strategicprograms • Basedonneed (idealistically?) • Currentlycovered (reality?) • Financial / Programmatic gaps $$$ $$ $

  10. 1. Costing Methods • Costing - determining the expenditure required to purchase the resources/ good/ inputs needed to achieve an activity or strategy • Budgeting - the allocation of resources to match requirements. • Once the cost of an activity is determined, the total number of desired activities will then determine the desired funding (case of treatment).

  11. 1. Costing cont. • In costing we identify and measure all the inputs and all the outputs. • Costs are always related to the outcomes they produce. Outcomes can also be called benefits or output. There are intermediate and final outcomes. • Some examples: • HIV treatment programmes: cost per life year gained • HIV prevention programmes: cost per HIV case prevented • At a more basic level, we often relate costs to certain activities, such as the cost of an inpatient day or the cost per outpatient visit

  12. Costs to be included • Direct– all the expenses incurred in delivering the health service, including shared costs • Indirect costs – those additional costs, usually from the perspective of the patient, in accessing treatment, eg. Transport, loss of productivity, etc • Intangible costs – those difficult to identify and measure eg. The drawbacks due to illness, depression, loss of quality of life • Recurrent costs - Resources that are used up within one year or costs that are incurred on an annual basis • Capital costs - Resources that last for more than one year (buildings, medical equipment, furniture, training of staff on HIV medicine and ART etc). • Shared costs - resources will be used jointly by the ART programme and other programmes in the health facility

  13. 2. Budget Monitoring Approach • Using the central and sub-national budget documents • Using the available line-items for the intended allocations for a sector (eg. Health), programme (eg. HIV/AIDS and STI), facility (eg. Hospitals/ clinics) • Undertake simple analysis with the nominal figures to ascertain: • Amount allocated – nominal & real terms (adjusted for inflation) • Increases from previous year (or more) ~ trends • Projected increases (if uses MTEF) • Proportional priorities ~ shares of total exp & GDP • Per capita allocation ~ adequacy (requires costing), regional comparison

  14. Prioritisation of Health ~ proportional analysis (Public Health as share of total expenditure) 18% Mozambique 16% Abuja target 14% Namibia - Total for MoHSS 12% South Africa 10% Namibia – Health specific 8% Kenya 6% 4% 2% 0% 2000/1 2001/2 2002/3 2003/4 2004/5 2005/6 Source: Guthrie & Hickey, 2004. ABU, Idasa.

  15. 3. Expenditures Tracking ~ What do we want to know? To describe the financial flows and actual expenditures for HIV and AIDS: • Who has promised/ committed/ allocated what? • Who pays (sources)? • Who manages the funds (financing agents)? • Who provides the services (providers)? • What was provided (functions/ASC: prevention, treatment, social mitigation, other sector activities)? • What are the budget components (Objects of expenditure)? • Who benefits from the spending (beneficiaries)? • Compare the budgeted/ allocated/ committed / transferred amounts with the actual expenditures

  16. Data Required to Understand Spending Programme/ Activity Programme/ Activity Programme/ Activity Programme/ Activity Programme/ Activity Programme/ Activity Programme/ Activity Programme/ Activity Adjusted from UNAIDS NASA approach.

  17. Source Provider Functions A C B Target Groups Objects of Expenditure Flow of resources from origin to end users: reconstruction of transactions Agent

  18. 4. Output Monitoring • Social Auditing • Citizen Score Cards • Service Satisfaction Surveys • Quality assessment of services • Counting numbers of beneficiaries, staff members, availability & quantity of drugs • These activities are better carried out by the community members / beneficiaries of the services • Clinical data – life years saved, QALYs, DALYs

  19. Eg. BMET : TB treatment in SA • Initially institutionalisation of TB pts • Advent of DOTS – needed evidence to prove was more cost-effective than institutionalisation • Then rolled out DOTS • With advent of HIV/AIDS, co-infection rates increased • Needed evidence to prove that ART would be cost-effective in reducing incidence of OIs (incl. TB), and that govt could afford to provide ARVs free to patients • Now calling for integrated treatment of HIV/AIDS and TB, and needing evidence to prove that TB prophylaxis for HIV-patients is cost effective • MDR-TB & XDR-TB… ?

  20. Using Financial Information for Evidence-Based Political Decisions

  21. Financial Sources for HIV/AIDS in EECA

  22. Financial Sources for HIV/AIDS in EECA

  23. Composition of HIV international sources – Swaziland (05/06 & 06/07)

  24. 400,000,000 350,000,000 300,000,000 International 250,000,000 funds 200,000,000 Public Funds Emalangenn 150,000,000 100,000,000 50,000,000 - 2005/2006 2006/2007 239,520,821 220,816,750 International funds 32,835,809 136,915,968 Public Funds Year Sources of HIV/AIDS Funds in Swaziland

  25. Spending Priorities in Swaziland

  26. Sources of HIV/AIDS Funds in Botswana (Pula)

  27. AIDS Categories in Botswana

  28. NSP Priorities vs Actual Spending - Zambia

  29. Region (All) IDU Spending, Needs and Expenditures in EECA* 2006 and 2007 $800,000 $700,000 $600,000 $500,000 $400,000 $300,000 $200,000 $100,000 $0 Bulgaria Croatia Georgia Kyrgyzstan Latvia Tajikistan Armenia Bulgaria Kazakstan Republic of Moldova 2006 2007 Data Total Expenditures Total Needs Reporting_Year Country *Armenia 2007, Bulgaria 2006-2007, Croatia 2006, Georgia 2006, Kazakhstan 2007, Kyrgyzstan 2006, Latvia 2006, Republic of Moldova 2007, Tajikistan 2006

  30. Opportunities for evidence-based political decisions • adequacy of funding – public & external • Public commitments-meeting national/international commitments ~ long-term sustainability • Comparison to costed NSP estimates of required resources – funding gap analysis • Centralised funding and spending with low funds for the sub-national level • Data not disaggregated according to national and sub-national levels • Discrepancies between allocations and actual expenditures ~ measurement of absorptive capacity, leakages, transaction costs

  31. Opportunities for evidence-based political decisions (2) • ALLOCATIVE DECISIONS – PRIORITIES • Meeting national priorities (aligned to NSP?) • Balance between programmes ~ unsustainability of treatment costs without adequate prevention interventions ~ allocative efficiency • Equity in allocations ~ between geographical areas, providers, beneficiaries & according to need • EFFICIENCY OF SPENDING • Provides varying unit costs for interventions, allows comparison of technical efficiency • Identifies poor absorption capacity ~ allows for exploration of factors: bottlenecks, dumping etc.

  32. Opportunities for evidence-based political decisions (3) • Coordination, Harmonisation and Alignment • Alignment of the actual HIV/AIDS spending to NSP – public and external • Agent analysis shows who determines use of funds • Identifies poor harmonisation – duplicative financing & reporting, high transaction costs • Institutionalization of NASA • Within the Monitoring and Evaluation (M&E) framework • Using standardised financial information/ reporting mechanisms

  33. Opportunities for evidence-based political decisions (4) • Enhanced Transparency, Accountability & Economic Governance • Increased pressure (& desire) for mutual accountability by all players • Promotes a (legal) framework to ensure all partners report through a national resource tracking system • Link framework to the National Resource Mobilisation and Management Strategy • Using the framework to harmonise standards of costing among different partners • Ensures transparent procurement systems & best pricing within and between countries & regions

  34. Opportunities for evidence-based political decisions (5) • Standardization & Comparability • Ensures standard classification of spending & activities within & between countries & regions • Provides comprehensive list of possible interventions • Resource needs estimates • Classification standardised with NASA • Package of interventions • Future requirements (funding gap) by programmes • Comparison of TFRR & TE

  35. So how to go about it…. • Broad consultation to discuss and decide what are the key issues requiring advocacy to bring about change • And how can budgetary and expenditure data strengthen the advocacy campaign • Be clear about your purpose

  36. Determining the purpose & intended outcomes • What are the key issues that you feel require an advocacy response? • What is your advocacy goal & intended outcomes? • What data is required to provide evidence to support the advocacy strategy? • Who will be the key audience of the findings? Who will be the likely supporters and the likely opposition? • What will be the focus/ topic of the project – OST, IDUs, HIV/AIDS, TB, health generally, health systems strengthening, ART?

  37. Planning the Project – Terms of Reference The scope of the project: • Which phase/s of the budget are being considered (need assessment, costing, resource allocation, processes), budgeted allocations analysis, expenditure analysis, output analysis, impact analysis) • Which years are to be covered • Which sources of funds (public and/or external and/or private, OOPE) • Which providers of services – all, only central or only district level, specific facilities, eg hospitals/ schools, etc etc? • Will the outputs and outcomes measured? Against what? • Efficiency analysis? (CBA, CEA, CUA?) • Is analysis of the beneficiary groups required? • Is analysis of the objects of expenditure required?

  38. Resource Tracking Process The broad steps in expenditure analysis: • Developing the project ToR ~ agree on purpose (advocacy goals), scope & methods & partners • Planning and preparation • Training & capacity building • Data Collection, Processing & Analysis • Preliminary findings validation & identification of advocacy campaigns / strategies • Final Report & Dissemination • Advocacy campaign implementation • On-going BMET by organisations involved

  39. Possible Country-Level Partnership Arrangements • The CORE Team could be made up of: • An organisation/s with economic or research skills • A Community level organisation &/or a strong advocacy org • Association of PLWHAs or PLWD/ Chln & Youth / Gender network (depending on your focus) • Members of the CORE team should be able to commit 2 or 3 people, 50% of their time, for at least 2yrs, hopefully 3yrs. • The REFERENCE group could include other key stakeholders whose input /assistance is necessary • Broader stakeholder group to identify issues, advocacy, etc • Select one org to be the country Co-ordinating agent • Identify suitable organisations to provide the tech. support

  40. Challenges in Monitoring Allocations & Expenditure Budget documents: • Do not give detail • Not actual expenditure • Non-standardised • Some donor contributions off-budget • Limited CS participation in allocative decisions • Allocations not based on need/ equity • Not used as a planning tool Expenditure records: • Not available/ accessible to CS • Not disaggregated (by programme/ facility / district) • Donors do not provide actual expenditure by recipients (vs commitmts/ disbursmts) • NHA data impt but not detailed sufficiently (esp.public sources) FOI laws in few countries or not used for accessing public expenditure records.

  41. CSO Challenges in BMET • Stronger on advocacy side • but often lacking technical capacity on ‘number-crunching’ • Stronger on the social auditing, citizen score cards, survey satisfaction surveys • but lacking skills for assessing efficiency of spending, absorptive capacity • BMET requires long-term commitment ito of HR and building capacity and transferring skills • Lack human capacity and usually over-stretched • Reliant of project-based funding – unreliable, unsustainable, no investment in institutional devmt

  42. Thank You For more information contact: • Teresa Guthrie • Centre for Economic Governance and AIDS in Africa • Email:teresa@cegaa.org • Teresa.cegaa@gmail.com • Tel: +27-82-872-4694 • Fax: +27-21-425-2852

More Related